←Back to Expert Scholars
Translational Medicine / 转化医学Gastric HER2/Claudin18.2
Manish Shah
MD
🏢Weill Cornell Medicine🌐USA
Chief, GI Oncology Division
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Manish Shah is a leading expert in molecularly targeted therapies for gastric and esophageal cancers. He has led multiple phase III trials evaluating anti-HER2 and anti-angiogenic agents in gastric cancer. His translational work on molecular subtypes has advanced precision medicine approaches in upper GI malignancies.
Share:
🧪Research Fields 研究领域
Gastric cancer
HER2 biomarkers
Anti-angiogenesis
Molecular profiling
Clinical trial design
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Manish Shah 的研究动态
Follow Manish Shah's research updates
留下邮箱，当我们发布与 Manish Shah（Weill Cornell Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment